Publisher
Springer Berlin Heidelberg
Reference8 articles.
1. Arndt R, Dürkopf H, Huland H, Donn F, Loening Th, Kalthoff H (1987) Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells. J Urol 137: 758–763
2. Huland H, Arndt R, Huland E, Loening Th, Steffens M (1987) Monoclonal antibody 486 P 3/12: A valuable bladder carcinoma marker for immunocytology. J Urol 137:654–659
3. Huland E, Huland H, Arndt R, Baisch H, Klöppel G (1988) Urindiagnostik oberflächlicher Harnblasentumoren durch Zytologie, Immunzytologie und Flowzytometrie: Ergebnisse einer prospektiven vergleichenden Studie an 104 Patienten. Aktuelle Urologie 19: 13–17
4. Huland E, Huland H, Meier Th, Baricordi O, Fradet Y, Grossmann HB, Hodges GM, Messing EM, Schmitz-Draeger BJ. (to be published) Comparison of 15 monoclonal antibodies against tumor-associated antigens.
5. J Urol Huland E, Huland H, Schneider AW (1990) Quantitative immunocytology in the management of patients with superficial bladder carcinoma. I. A marker to identify patients, who do not require prophylaxis. J Urol. 144: 637–640